University Hospital
Welcome,         Profile    Billing    Logout  
 4 Trials 
8 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Thompson, Alastair
NCT04379570: Additional Support Program Via Text Messaging and Telephone-Based Counseling for Breast Cancer Patients Receiving Hormonal Therapy

Recruiting
3
1180
US
Educational Intervention, Text Message-based Navigation Intervention, Motivational Interviewing, Best Practice, Standard of Care, Questionnaire Administration, Quality-of-Life Assessment
Alliance for Clinical Trials in Oncology, National Cancer Institute (NCI)
Anatomic Stage I Breast Cancer AJCC V8, Anatomic Stage II Breast Cancer AJCC V8, Anatomic Stage III Breast Cancer AJCC V8, HER2 Negative Breast Carcinoma, Hormone Receptor Positive Breast Carcinoma, Invasive Breast Carcinoma, Prognostic Stage I Breast Cancer AJCC V8, Prognostic Stage II Breast Cancer AJCC V8, Prognostic Stage III Breast Cancer AJCC V8
10/26
10/26
SENTINOT_2, NCT04722692: Delayed Sentinel Lymph Node Biopsy in Ductal Cancer in Situ

Recruiting
3
500
Europe, US, RoW
Delayed SLND, Late SLND
Uppsala University, Västmanlands Hospital, Västerås, Sweden, Sahlgrenska University Hospital, Sweden, University Hospital, Linkoeping, Skane University Hospital, Blekinge County Council Hospital, Växjö Hospital, Växjö, Sweden, The University of Hong Kong-Shenzhen Hospital, Norrlands University Hospital, Dalarna County Hospital, Falun, Sweden, Baylor College of Medicine
DCIS, Breast Cancer, Breast Neoplasms, Sentinel Lymph Node
12/26
12/27
MAGELLAN, NCT03796559: Magseed Enabled Long-Term Localization of Axillary Lymph Nodes

Recruiting
N/A
65
US
Magseed Marker
Endomagnetics Ltd., M.D. Anderson Cancer Center
Breast Cancer, Axillary Lymph Nodes
02/26
05/26
RCT, NCT05113927: Wide Field OCT + AI for Positive Margin Rates in Breast Conservation Surgery.

Completed
N/A
482
US
Selene
Perimeter Medical Imaging, Cancer Prevention Research Institute of Texas, Proxima Clinical Research, Biostatistical Consulting, Inc.
Breast Cancer
09/24
10/24
PROSPECTIVE, NCT06445738: Post-operative Radiotherapy Omission in Selected Patients with Early Breast Cancer Trial International VErsion

Not yet recruiting
N/A
1400
RoW
Arm A: Radiotherapy Omission, A1: Grade 1 or 2/HER2 negative; A2: Grade 3 and/or HER2 positive, Arm B: Standard Treatment
Breast Cancer Trials, Australia and New Zealand
Breast Cancer, Breast Cancer Female
03/32
03/39
ANGEL, NCT06085833: ARTIDIS Nanomechanical Generated Measurements for Early Breast Lesions

Recruiting
N/A
2706
US
Nanomechanical Phenotype Test
ARTIDIS AG
Breast Cancer
10/25
11/35
PREDICT, NCT03448926: The Registry:

Recruiting
N/A
3000
US
Treatment Recommendation Surveys, 7-gene biosignature
PreludeDx, University of South Florida
DCIS
12/25
12/35
COMET, NCT02926911: Comparing an Operation to Monitoring, With or Without Endocrine Therapy () Trial For Low Risk DCIS

Active, not recruiting
N/A
997
US
Surgery, Active Monitoring
Alliance Foundation Trials, LLC., Duke University, Dana-Farber Cancer Institute, New York University, Washington University School of Medicine, Patient-Centered Outcomes Research Institute, The University of Texas MD Anderson Cancer Center, Rising Tide Foundation, Breast Cancer Research Foundation
DCIS, Ductal Carcinoma in Situ
06/24
07/28

Download Options